LCZ696 THERAPY IS ASSOCIATED WITH IMPROVEMENT OF VENTRICULAR ARTERIAL COUPLING AND WORK EFFICIENCY IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION

被引：0
|
作者：
Kobalava, Z. [1 ]
Babaeva, L. [1 ]
Lukina, O. [1 ]
Zharikova, E. [1 ]
Tyukhmenev, E. [1 ]
Villevalde, S. [1 ]
机构：
[1] PFUR, Moscow, Russia
来源：
JOURNAL OF HYPERTENSION | 2016年 / 34卷
关键词：
D O I：
10.1097/01.hjh.0000492025.22857.94
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
PP.20.01
引用
收藏
页码：E239 / E239
页数：1
相关论文
共 50 条
  • [1] LCZ696 vs. enalapril in heart failure patients with reduced ejection fraction
    Laffman-Johnson, Elise
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (06) : 634 - 634
  • [2] Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction
    Kobalava, Zhanna
    Kotovskaya, Yulia
    Averkov, Oleg
    Pavlikova, Elena
    Moiseev, Valentine
    Albrecht, Diego
    Chandra, Priya
    Ayalasomayajula, Surya
    Prescott, Margaret F.
    Pal, Parasar
    Langenickel, Thomas H.
    Jordaan, Pierre
    Rajman, Iris
    CARDIOVASCULAR THERAPEUTICS, 2016, 34 (04) : 191 - 198
  • [3] Early improvement of symptoms using LCZ696 in a patient with systolic heart failure and a reduced ejection fraction: a case report
    Kohlmeier, Johannes
    Bramlage, Peter
    PERFUSION-UK, 2016, 31 (08): : 699 - 702
  • [4] The Angiotensin Receptor Neprilysin Inhibitor LCZ696 is Effective Across the Spectrum of Ejection Fraction in Heart Failure With Reduced Ejection Fraction
    Solomon, Scott
    Packer, Milton
    Zile, Michael
    Swedberg, Karl
    Rouleau, Jean
    Letkowitz, Martin
    Shi, Victor
    Desai, Akshay
    Claggett, Brian
    Starling, Randall
    McMurray, John J. V.
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (08) : S45 - S46
  • [5] The cost-effectiveness of sacubitril/valsartan (LCZ696) in the treatment of patients with heart failure with reduced ejection fraction in Norway
    Gundersen, V.
    Eklund, O.
    Hancock, E.
    Hussain, R.
    Ohna, A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 203 - 203
  • [6] LCZ696 as a bridge to candidacy to valve surgery in patients with advanced heart failure with reduced ejection fraction: a case report
    Pellegrini, D.
    Villani, A.
    Oldani, M.
    Gerometta, P.
    Malfatto, G.
    Parati, G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 180 - 181
  • [7] Impairment of ventricular-arterial coupling and work efficiency in patients with arterial hypertension and heart failure with reduced ejection fraction
    Akhmetov, R.
    Villevalde, S.
    Moiseev, V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 218 - 218
  • [8] Direct actions of dapagliflozin and interactions with LCZ696 and spironolactone on cardiac fibroblasts of patients with heart failure and reduced ejection fraction
    Ortega-Paz, Luis
    Cristobal, Helena
    Tomas Ortiz-Perez, Jose
    Garcia de Frutos, Pablo
    Mendieta, Guiomar
    Sandoval, Elena
    Jose Rodriguez, Juan
    Ortega, Emilio
    Garcia-Alvarez, Ana
    Brugaletta, Salvatore
    Sabate, Manel
    Paula Dantas, Ana
    ESC HEART FAILURE, 2023, 10 (01): : 453 - 464
  • [9] A patient with symptomatic heart failure with preserved left ventricular ejection fraction and right sided heart failure treated with LCZ696
    Cafka, M.
    Xhanaj, J.
    Zace, E.
    Duka, A.
    Seiti, J.
    Balla, I.
    Goda, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 347 - 347
  • [10] Renal effects of lcz696 in patients with heart failure and preserved ejection fraction: results from paramount
    Voors, A. A.
    Gori, M.
    Liu, C. Y. L.
    Zile, M.
    Pieske, B.
    Mc Murray, J. J. V.
    Packer, M.
    Bransford, T.
    Lefkowitz, M.
    Solomon, S. D.
    EUROPEAN HEART JOURNAL, 2013, 34 : 668 - 668
12345